Vertex Pharmaceuticals
Biotechnology Research • Boston, United States
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, aut…
Headcount
0
5001-10,000 employees
Hiring
0
Open roles
Revenue Signal
2B
Estimated annual revenue
Last Round
$0
Most recent funding amount
